A similar study, in which patients with impaired fasting glucose levels were treated with atorvastatin for 16 weeks, noted a trend towards improved insulin sensitivity in the treatment group, as determined by oral glucose tolerance test, but this trend failed to reach significance ( Costa et al 2003 ).
1
—
—